Case Description/ Methods: A 37-year-old woman with obesity on semaglutide presented with two days of intractable left-sided abdominal pain, constipation, nausea, and vomiting
Without lifestyle changes, weight regain is possible
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two primary indications: type 2 diabetes management and chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Holistic support includes: Ensuring nutrient-dense meals
This article is not a substitute for medical advice, diagnosis, or treatment
As research into PT-141 expands, its reputation as the best peptide for erectile dysfunction includes benefits for both men and women